Effect of Age on the Conformity Rate to Short-Acting Beta-Agonist Use Criteria in Asthma

By Labrecque M.   Laurier C.   Champagne F.   Kennedy W.   Paré M.   Cartier A.  

Journal of Asthma, Vol. 40, Iss. 7, 2003-01 ,pp. : 829-835

Informa Healthcare

Access to resources Recommend Favorite

The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation

By Neuspiller F   Levy M   Remohi J   Ruiz A   Simon C   Pellicer A  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1148-1151

Oxford University Press

Access to resources Recommend Favorite

Three Generations of Ongoing Controversies Concerning the Use of Short Acting Beta-Agonist Therapy in Asthma: A Review

By Jalba Mihai-Sergiu  

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 9-18

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β₂-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler

By Berger William E.   Noonan Michael J.  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 447-459

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Inhaled Corticosteroids in Combination with a Long-Acting Beta 2 -Agonist in Asthmatic Children Under Age 5

By Sekhsaria Sudhir   Alam Mikhayl   Sait Tahir   Starr Barnaby   Parekh Monica  

Journal of Asthma, Vol. 41, Iss. 5, 2004-01 ,pp. : 575-582

Informa Healthcare

Access to resources Recommend Favorite